Mesterolone

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

220pxpx }}
Mesterolone
Systematic (IUPAC) name
 ?
Identifiers
CAS number 1424-00-6
ATC code G03BB01
PubChem 15020
Chemical data
Formula C20H32O2 
Mol. mass 304.467 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

WikiDoc Resources for

Mesterolone

Articles

Most recent articles on Mesterolone

Most cited articles on Mesterolone

Review articles on Mesterolone

Articles on Mesterolone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mesterolone

Images of Mesterolone

Photos of Mesterolone

Podcasts & MP3s on Mesterolone

Videos on Mesterolone

Evidence Based Medicine

Cochrane Collaboration on Mesterolone

Bandolier on Mesterolone

TRIP on Mesterolone

Clinical Trials

Ongoing Trials on Mesterolone at Clinical Trials.gov

Trial results on Mesterolone

Clinical Trials on Mesterolone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mesterolone

NICE Guidance on Mesterolone

NHS PRODIGY Guidance

FDA on Mesterolone

CDC on Mesterolone

Books

Books on Mesterolone

News

Mesterolone in the news

Be alerted to news on Mesterolone

News trends on Mesterolone

Commentary

Blogs on Mesterolone

Definitions

Definitions of Mesterolone

Patient Resources / Community

Patient resources on Mesterolone

Discussion groups on Mesterolone

Patient Handouts on Mesterolone

Directions to Hospitals Treating Mesterolone

Risk calculators and risk factors for Mesterolone

Healthcare Provider Resources

Symptoms of Mesterolone

Causes & Risk Factors for Mesterolone

Diagnostic studies for Mesterolone

Treatment of Mesterolone

Continuing Medical Education (CME)

CME Programs on Mesterolone

International

Mesterolone en Espanol

Mesterolone en Francais

Businness

Mesterolone in the Marketplace

Patents on Mesterolone

Experimental / Informatics

List of terms related to Mesterolone

Mesterolone is an orally applicable androgen, and DHT derivative. It is sold under the brand name Proviron, by Schering. In the late 70's and early 80's it was used with some success in controlled studies of men suffering from various forms of depression.

In one randomized, double-blind 4-week trial, 38 dysthymic men were administered 75mg daily. Itil & Colleagues reported an improvement of symptoms which included anxiety, lack of drive and desire. Next, they administered a high dose (450mg/day) or placebo in a 6-week randomized trial of 52 men with a mean age of 40 years, suffering from dysthymia, unipolar and bipolar depression. Both the mesterolone and placebo groups improved significantly and there were no statistically significant differences between the two groups. In this series of studies mesterolone lead to a significant decrease in LH and testosterone levels. This is probably as a result of the extremely high dose used. In another, 100mg mesterolone cipionate was administered twice monthly. With regards to plasma T levels, there was no difference between the treated vs untreated group, and baseline LH levels were minimally affected.[1]

Mesterolone is a relatively weak androgen and rarely used for replacement therapies.[1]


References


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools